TACE IN INDIA
CENTRES, COSTS AND ACCESS
India's leading cancer and liver disease centres perform TACE at costs 60–80% below the UK and USA, with English-speaking care teams, JCI-accredited facilities, and growing interventional radiology expertise — making India one of the most accessible TACE destinations for international patients.
analyticsAt a Glance
- check_circleTACE at top Indian centres costs USD 5,000–14,000 all-inclusive — compared to USD 40,000–80,000 in the United States
- check_circleTata Memorial Hospital (Mumbai) is India's premier cancer institution — highest oncology volume in South Asia
- check_circleApollo Hospitals, Fortis, and Medanta operate JCI-accredited facilities with dedicated international patient departments
- check_circleParticularly accessible for patients from South Asia, Gulf States, East and West Africa, and the United Kingdom
India's Emerging Strength in Liver Cancer Interventional Oncology
India's academic and private hospital systems have developed strong interventional radiology and hepatobiliary oncology programmes over the past two decades, driven by the high incidence of hepatitis B and C in South Asian populations and the resulting HCC burden. Indian programmes offer TACE at costs that are a fraction of Western equivalents — with quality infrastructure, English-speaking care teams, and regulatory systems compatible with international medical tourism standards.
“India offers something that neither Western nor some Chinese programmes can match: English as the primary language of care, cultural familiarity for South Asian and Gulf patients, and costs that make multiple TACE sessions financially feasible for families who cannot access or afford Western healthcare.”
Why India Is the Access Choice for Specific Patient Populations
For patients from South Asia (Bangladesh, Pakistan, Sri Lanka, Nepal), the Gulf Cooperation Council (UAE, Saudi Arabia, Kuwait, Qatar), East Africa, and the UK, India offers a uniquely accessible combination: direct flight connections (2–5 hours from most Gulf and South Asian cities), no language barrier in English, familiar dietary options, and a visa-on-arrival or e-visa system that is simpler than Chinese medical visa requirements.
JCI Accreditation and Quality Standards
Multiple Indian hospital groups — Apollo, Fortis, Medanta, and Manipal Hospitals — hold Joint Commission International (JCI) accreditation, the same quality standard that applies to US and European hospitals. Tata Memorial Centre (Mumbai) is accredited by the National Accreditation Board for Hospitals (NABH) and is the WHO Collaborating Centre for Cancer Control in India. These accreditations ensure processes, clinical protocols, and safety standards are independently audited.
Leading Indian TACE and Liver Cancer Centres
The following institutions operate established interventional radiology and hepatobiliary programmes with documented TACE capability and international patient infrastructure.
| Centre | City | Primary Strengths | International Patient Infrastructure |
|---|---|---|---|
| Tata Memorial Hospital (TMC) | Mumbai | Highest cancer volume in India; dedicated hepatobiliary tumour group; TACE, RFA, HAIC, and surgical resection; research programme | NABH accredited; oncology-specific international patient unit; English-speaking physicians; volume HCC programme |
| Apollo Hospitals (Greams Road) | Chennai | JCI accredited; integrated hepatology-IR-surgical oncology; liver transplant programme; robust international patient pathway | Dedicated international patient services; English throughout; 30+ countries served; insurance billing support |
| Fortis Memorial Research Institute | Gurugram | JCI accredited; HPB surgery and interventional radiology combined programme; liver transplant unit; large IR department | Dedicated international affairs team; airport pickup; accommodation coordination; strong Gulf/UK patient base |
| Medanta — The Medicity | Gurugram | Institute of Liver Transplantation and Regenerative Medicine; full HCC treatment spectrum including TACE, ablation, resection | International patient coordinators; 24-hour helpline; interpreter services; accommodation near hospital |
| Lilavati Hospital and Research Centre | Mumbai | Strong hepatology and interventional radiology; high-volume gastroenterology and liver programme | Private hospital; English-speaking; accessible from Mumbai international airport; mid-tier cost |
| Manipal Comprehensive Cancer Centre | Bengaluru | NABH accredited; growing liver cancer programme; TACE and ablation; multidisciplinary tumour board | South India base; accessible from UAE and Gulf; English-speaking; emerging international patient programme |
| Asian Institute of Gastroenterology (AIG) | Hyderabad | Premier gastroenterology and hepatology institution in South India; liver transplant and advanced IR | Strong international reputation; Telugu, Hindi, English; accessible for Gulf patients; growing oncology capability |
TACE Cost in India vs Other Countries
All-inclusive TACE cost comparison for a single session including procedure, drugs, hospital stay, and post-procedure monitoring.
All-Inclusive TACE Cost Per Session — India vs Comparators
All-inclusive hospital fees: procedure + drugs + sedation + 1–3 night stay + blood tests. Travel and accommodation not included.
- India (top private hospital)USD 5,000–14,000
- China (Tier 3A academic centre)USD 8,000–18,000
- UK (private hospital)USD 18,000–35,000
- United StatesUSD 40,000–80,000
India vs China for TACE: How to Choose
Both are high-quality, cost-effective options. The choice depends on practical and clinical factors specific to your situation.
Choose India When
- Your native language is English or South AsianEnglish is the primary language of clinical care at major Indian hospitals — no interpreter required. Culturally familiar for South Asian, Gulf, and East African patients.
- You are based in South Asia, Gulf, or East AfricaFlight time of 2–5 hours from most Gulf and South Asian cities; visa-on-arrival or e-visa for most nationalities. Far more geographically accessible than Shanghai for these populations.
- Budget is the primary constraintIndian TACE costs are generally slightly lower than equivalent Chinese programmes for comparable procedures — particularly for patients from low- and middle-income countries.
- Liver transplant is under concurrent considerationIndia has active liver transplant programmes at Apollo, Medanta, and Fortis — if transplant eligibility is part of the treatment goal, India offers full continuity of care within one system.
Choose China When
- HAIC or HAIC + lenvatinib is the indicated treatmentHAIC programmes are more extensively developed at Chinese centres (Zhongshan, SYSUCC, Fudan) than Indian programmes — for PVTT-associated advanced HCC, Chinese centres have more volume and outcomes data.
- Your HCC is BCLC C with portal vein involvementChinese centres have published the most extensive HAIC data for BCLC C disease and apply TACE + systemic combinations more routinely than most Indian programmes currently.
- Access to TACE + immunotherapy combinationsThe EMERALD-1 and TACTICS protocols are most consistently implemented at high-volume Chinese liver cancer programmes with active clinical trial infrastructure.
- Mandarin is spoken or cultural familiarity with China existsFor Chinese diaspora patients or those with existing connections to China, Chinese centres remove cultural and linguistic barriers that CancerFax's interpreter service mitigates but does not eliminate.
TACE in India: Key Numbers
Practical reference figures for international patients planning TACE in India.
- USD 5,000–14,000All-inclusive TACE cost range at top Indian private hospitalsThe most cost-accessible TACE destination for patients from South Asia, the Gulf, and Africa — 5–10× less expensive than equivalent procedures in the United States.
- 60–70%Cost saving vs United States for equivalent TACE procedureThe same procedure with the same drug (DEB-TACE with doxorubicin), equivalent hospital infrastructure and monitoring, at a fraction of the US price.
- 3–5 daysMinimum in-country stay for TACE at Indian hospitalsAdmission day + procedure day + 1–2 recovery days + pre-discharge blood tests and review. Most uncomplicated TACE patients can safely travel home after 4–5 days in India.
- JCIQuality accreditation at leading Indian hospital groups (Apollo, Fortis, Medanta)The same international quality standard that applies to US and European hospitals — independently audited clinical and safety processes.
More from the TACE Resource Library
Continue exploring TACE access options globally.
- Zhongshan Hospital Shanghai: One of the World's Leading TACE Centres
- TACE Cost Comparison: China vs India vs Western Countries
- Accessing TACE Through CancerFax: Patient Navigation Guide
- Questions to Ask Before and During TACE Treatment
- What Is TACE? A Patient Introduction to Liver Cancer Embolisation
- TACE Therapy — Complete Treatment Guide
Frequently Asked Questions
Common questions from patients exploring TACE in India.
About TACE in India
How do I know if an Indian hospital's TACE programme is experienced enough?
The key quality indicators for any TACE programme apply in India as they do elsewhere: annual procedure volume (aim for centres performing >50 TACE procedures per year); availability of a hepatobiliary MDT that includes interventional radiology, hepatology, surgery, and oncology; published or audited complication rates; and access to liver transplant services for patients on the transplant pathway. JCI accreditation provides a process quality floor but does not specifically measure TACE volume or outcomes. CancerFax evaluates Indian centres on these specific metrics before recommending them for hepatic oncology cases — we do not refer liver cancer patients to hospitals based on general reputation alone. Ask any centre directly: 'How many TACE procedures do you perform annually, and what is your 30-day complication rate?'
I am from Bangladesh — what is the easiest way to come to India for TACE?
Bangladesh has a relatively streamlined medical visa pathway to India. For medical treatment at a recognized hospital, Bangladeshi patients apply for an Indian Medical Visa (M-Visa) — which requires a letter from the Indian hospital confirming the intended treatment and appointment date. CancerFax provides this hospital invitation letter as part of the standard coordination service. The Dhaka to Mumbai or Delhi flight is 2.5–4 hours, and major Indian airports have immigration fast-track for medical visa holders. For Bangladeshi patients with HCC, Tata Memorial in Mumbai is the most commonly recommended destination due to its oncology specialisation and cost profile. CancerFax can arrange the complete pathway from visa documentation through discharge.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Access TACE in India Through CancerFax
CancerFax reviews your imaging, Child-Pugh score, and BCLC stage and connects you with the most appropriate Indian TACE centre for your specific case — managing consultation scheduling, record translation, hospital registration, and follow-up coordination.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.